Marek Jarema

Marek Jarema

UNVERIFIED PROFILE

Are you Marek Jarema?   Register this Author

Register author
Marek Jarema

Marek Jarema

Publications by authors named "Marek Jarema"

Are you Marek Jarema?   Register this Author

59Publications

-Reads

Hypersomnia and cognitive impairment in a patient with bipolar disorder - a case report.

Psychiatr Pol 2017 Jun 18;51(3):483-494. Epub 2017 Jun 18.

III Klinika Psychiatryczna, Instytut Psychiatrii i Neurologii w Warszawie.

View Article
June 2017

Effects of cognitive remediation therapy versus other interventions on cognitive functioning in schizophrenia inpatients.

Neuropsychol Rehabil 2017 May 1:1-12. Epub 2017 May 1.

c Department of Psychology , Institute of Psychiatry, King's College London , London , United Kingdom.

View Article
May 2017

Letter to Editor. In search of definition of the term "psychotic process" - thoughts and doubts.

Psychiatr Pol 2017 Apr 30;51(2):383-386. Epub 2017 Apr 30.

III Klinika Psychiatryczna, Instytut Psychiatrii i Neurologii w Warszawie.

View Article
April 2017

Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.

Psychiatr Pol 2017 Feb 26;51(1):7-21. Epub 2017 Feb 26.

Klinika Psychiatrii Dorosłych UM w Poznaniu.

View Article
February 2017

Clinical determinants of mental disorders occurring during the infertility treatment.

Psychiatr Pol 2015 ;49(5):965-82

III Klinika Psychiatryczna IPiN w Warszawie.

View Article
December 2016

Body Image and Body Experience Disturbances in Schizophrenia: an Attempt to Introduce the Concept of Body Self as a Conceptual Framework.

Curr Psychol 2018 25;37(1):390-400. Epub 2016 Nov 25.

2III Psychiatric Clinic, Institute of Psychiatry and Neurology, Sobieskiego 9 Street, 02-957 Warsaw, PL Poland.

View Article
November 2016

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: Neurophysiology.

World J Biol Psychiatry 2015 ;16(5):280-90

Department of Psychiatry, University Hospital Cochin (site Tarnier), University of Paris-Descartes, INSERM U 894 Centre Psychiatry and Neurosciences , Paris , France.

View Article
May 2016

Letter to the editors.

Int J Psychiatry Clin Pract 2007 ;11(1):81

Department of Adult Psychiatry, Pozhan University of Medical Sciences, Pozhan, Poland.

View Article
October 2015

[Guidelines for the use of second-generation long-acting antipsychotics].

Psychiatr Pol 2015 Mar-Apr;49(2):225-41

Klinika Psychiatrii Dorosłych Uniwersytetu Medycznego im. K. Marcinkowskiego w Poznaniu.

View Article
August 2015

Functional polymorphism of matrix metalloproteinase-9 (MMP9) gene is not associated with schizophrenia and with its deficit subtype.

Pharmacol Rep 2015 Jun 27;67(3):442-5. Epub 2014 Nov 27.

Department of Clinical Psychology, Institute of Psychology, University of Szczecin, Szczecin, Poland. Electronic address:

View Article
June 2015

Electroencephalographic theta activity and cognition in schizophrenia: preliminary results.

World J Biol Psychiatry 2015 Apr 24;16(3):206-10. Epub 2014 Oct 24.

Third Department of Psychiatry, Institute of Psychiatry and Neurology , Warsaw , Poland.

View Article
April 2015

[Cognitive dysfunctions in depression - underestimated symptom or new dimension?].

Psychiatr Pol 2014 Nov-Dec;48(6):1105-16

Klinika Psychiatrii UM w Lublinie.

View Article
April 2015

[Cognitive rehabilitation for people living with schizophrenia - the newest interventions].

Psychiatr Pol 2014 Nov-Dec;48(6):1179-88

III Klinika Psychiatryczna IPiN w Warszawie.

View Article
April 2015

Age or age at onset? Which of them really matters for neuro and social cognition in schizophrenia?

Psychiatry Res 2015 Jan 24;225(1-2):197-201. Epub 2014 Nov 24.

Third Department of Psychiatry, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957 Warsaw, Poland.

View Article
January 2015

Daytime sleepiness and EEG abnormalities in patients treated with second generation antipsychotic agents.

Pharmacol Rep 2014 Dec 2;66(6):1077-82. Epub 2014 Aug 2.

Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, Poland. Electronic address:

View Article
December 2014

[Between health and schizophrenia].

Psychiatr Pol 2013 Jul-Aug;47(4):587-97

View Article
September 2014

Long-term assessment of the efficacy and tolerability of risperidone in early schizophrenia: An international multicenter study.

Int J Psychiatry Clin Pract 2004 ;8(3):147-52

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.

View Article
June 2014

Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study.

J Clin Psychiatry 2014 Apr;75(4):362-8

University of Cape Town Department of Psychiatry, Groote Schuur Hospital, J-Block, Anzio Rd, Observatory, Cape Town 7925, South Africa

View Article
April 2014

Treatment of depression in first episode of schizophrenia: results from EUFEST.

Eur Neuropsychopharmacol 2012 Dec 23;22(12):875-82. Epub 2012 May 23.

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.

View Article
December 2012

Cytokines, sleep and wakefulness regulation, and general health: a commentary to the review "The influence of cytokines on wakefulness regulation".

Psychiatr Danub 2012 Jun;24(2):127-9

Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland.

View Article
June 2012

Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone.

J Psychiatr Res 2011 Oct 15;45(10):1381-6. Epub 2011 Jun 15.

Third Department of Psychiatry, Institute of Psychiatry and Neurology, Sobieskiego, Warsaw, Poland.

View Article
October 2011

[Practical aspects of the use of ziprasidone in schizophrenia].

Psychiatr Pol 2010 Nov-Dec;44(6):881-93

III Klinika Psychiatryczna IPiN w Warszawie.

View Article
May 2011

[Antipsychotics in clinical practice. Treatment of the first schizophrenic episode].

Psychiatr Pol 2008 Nov-Dec;42(6):841-58

III Klinika Psychiatryczna IPiN w Warszawie.

View Article
June 2009

Herbal drug treatment.

Authors:
Marek Jarema

Neuro Endocrinol Lett 2008 Nov;29 Suppl 1:93-104

3rd Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, Poland.

View Article
November 2008

Biological treatment of mental disorders.

Authors:
Marek Jarema

Neuro Endocrinol Lett 2008 Nov;29 Suppl 1:1-4

View Article
November 2008

A few facts from the history of selected biological treatment methods in psychiatry.

Authors:
Marek Jarema

Neuro Endocrinol Lett 2008 Nov;29 Suppl 1:5-9

3rd Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, Poland.

View Article
November 2008

[Pharmacological standards in schizophrenia treatment].

Psychiatr Pol 2006 Nov-Dec;40(6):1171-205

Grupa Robocza powołana przez Konsultanta Krajowego w dziedzinie psychiatrii dia opracowania Standardów Leczenia w Psychiatrii.

View Article
May 2007

Strategies of long-term treatment of psychotic disorders.

Authors:
Marek Jarema

Neuro Endocrinol Lett 2007 Feb;28 Suppl 1:13-26

III Department of Psychiatry, Institute of Psychiatry and Neurology, Ul. Sobieskiego 9, 02-9578 Warszawa, Poland.

View Article
February 2007

Atypical antipsychotics in the treatment of mood disorders.

Authors:
Marek Jarema

Curr Opin Psychiatry 2007 Jan;20(1):23-9

III Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland.

View Article
January 2007

[Subjective and objective evaluation of olanzapine treatment in schizophrenia].

Psychiatr Pol 2004 Sep-Oct;38(5):895-909

III Kliniki Psychiatrycznej IPiN w Warszawie.

View Article
January 2005

[Second generation antipsychotics: similarities and differences].

Psychiatr Pol 2003 Jan-Feb;37(1):7-28

III Kliniki Psychiatrycznej IPiN w Warszawie.

View Article
July 2003

[Second generation of neuroleptics--expectations and the reality].

Authors:
Marek Jarema

Psychiatr Pol 2002 Nov-Dec;36(6 Suppl):209-16

III Klinika Psychiatryczna Instytutu Psychiatrii i Neurologii w Warszawie.

View Article
June 2003

[Current concepts of pharmacological treatment in schizophrenia].

Authors:
Marek Jarema

Psychiatr Pol 2002 Nov-Dec;36(6):857-68

III Kliniki Psychiatrycznej IPiN w Warszawie.

View Article
June 2003

[The change of quality of life and clinical picture in schizophrenia].

Psychiatr Pol 2002 May-Jun;36(3):393-402

III Kliniki Psychiatrycznej IPiN w Warszawie.

View Article
September 2002